Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 3,887 | 3,148 | 6,803 | 3,095 | 3,363 |
| Gross Profit | 3,887 | 3,148 | 6,803 | 3,095 | 3,363 |
| Operating Expenses | 28,635 | 27,758 | 29,546 | 21,744 | 19,941 |
| Operating Income | -24,748 | -24,610 | -22,743 | -18,649 | -16,578 |
| Interest Expense | 982 | 969 | 956 | 975 | 201 |
| Other Income | 2,733 | 1,534 | 1,136 | 901 | 534 |
| Pre-tax Income | -22,997 | -24,045 | -22,563 | -18,723 | -16,245 |
| Net Income Continuous | -22,997 | -24,045 | -22,563 | -18,723 | -16,245 |
| Net Income | $-22,997 | $-24,045 | $-22,563 | $-18,723 | $-16,245 |
| EPS Basic Total Ops | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 |
| EPS Basic Continuous Ops | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 |
| EPS Diluted Total Ops | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 |
| EPS Diluted Continuous Ops | -0.24 | -0.51 | -0.93 | -0.78 | -0.67 |
| EBITDA(a) | $-23,462 | $-23,314 | $-21,244 | $-17,165 | $-15,327 |